Neuberger Berman Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Neuberger Berman Group's ABBV Position: Q3 2026 in Review
Neuberger Berman Group increased its AbbVie (ABBV) stake by 44% in Q3 2026, buying an estimated $146M and bringing the position to 1,848,306 shares worth $484M. The position accounts for 0.33% of the portfolio, ranked #55.
Neuberger Berman Group first reported a position in ABBV in Q2 2013 and has held it in 54 quarters since. The position peaked at $490M in Q4 2023. 4,258 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Neuberger Berman Group held 1,848,306 shares of AbbVie worth $484M as of Q3 2026.
- Neuberger Berman Group bought 569,131 AbbVie shares in Q3 2026, an estimated $146M.
- AbbVie made up 0.33% of Neuberger Berman Group's portfolio in Q3 2026, its #55 holding.
- Neuberger Berman Group first reported a position in AbbVie in Q2 2013 and has held it in 54 quarters since.
- Neuberger Berman Group's AbbVie position peaked at $490M in Q4 2023.
- 4,258 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.